This grant, offered by the National Cardiovascular Health Department, focuses on implementing and evaluating evidence-based strategies for the prevention and management of Cardiovascular Disease (CVD). Targeting populations at the highest risk, this initiative strongly emphasizes health equity by addressing critical social and economic factors impacting health outcomes. The funding aims to enable health systems to effectively respond to social determinants within their communities, ensuring optimal health outcomes for individuals at risk of, or burdened with, CVD. This grant is for the purpose of fostering equitable health solutions and reducing disparities in cardiovascular health across communities.
Opportunity ID: 342935
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DP-23-0004 |
| Funding Opportunity Title: | The National Cardiovascular Health Program |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 51 |
| Assistance Listings: | 93.426 — Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 24, 2023 |
| Last Updated Date: | Feb 24, 2023 |
| Original Closing Date for Applications: | Apr 25, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Apr 25, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | May 25, 2023 |
| Estimated Total Program Funding: | $275,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $850,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments |
| Additional Information on Eligibility: | Per the program’s authorizing statute or regulation: Sec 317(a) of the Public Health Service Act [42 USC 247b] only State governments, including the District of Columbia, or their bona fide agents are eligible to apply. Local health departments are eligible to compete under a separate NOFO (The Innovative Cardiovascular Health Program), and Tribes and Tribal-serving organizations are and will continue to be funded under separate NOFOs (https://www.cdc.gov/healthytribes/index.htm). FY22 House Report language asserts the significant increases to DHDSP’s budget allocations should be directed to “support, strengthen, and expand current evidence-based initiatives at the State, local, tribal, and territorial level.” Committee language further supports a continuation of DHDSP’s current efforts and “recognizes the vital importance of addressing cardiovascular disease among women and underserved communities, communities of color, those communities with limited access to information about cardiovascular health disease, and communities at risk for delaying regular monitoring of cardiovascular health as a result of the COVID–19 pandemic. The Committee supports CDC’s efforts to improve our understanding of the outcomes and health effects of COVID–19 infection, including cardiovascular disease.” [House Committee Report 117-96, p. 89. Available at: CRPT-117hrpt96.pdf (congress.gov)]More recently, FY23 House Report language directs efforts to “support, strengthen, and expand evidence-based initiatives at the State, local, tribal, and territorial level. The Committee recognizes the vital importance of addressing cardiovascular disease among women, particularly women of color, and further recognizes that the resulting costs to the health care system of unrecognized cardiovascular disease in women can be substantially reduced with appropriate public awareness and prevention”. [FY23 House Report 117-403, p. 80. Available at:CRPT-117hrpt403.pdf (congress.gov)] FY23 Explanatory Statement asserts the agreement includes an increase to strengthen and expand evidence-based heart disease and stroke prevention activities focused on high risk populations. Applicants should refer to the funding table for specific funding amounts for each state. |
Additional Information
| Agency Name: | Centers for Disease Control – NCCDPHP |
| Description: | This NOFO aims to implement and evaluate evidence-based strategies contributing to the prevention and management of CVD in populations at the highest risk. However, given the importance of health equity, this new NOFO also addresses social and economic factors to help health systems respond to social determinants present in their communities to offer those at risk of, or burdened with CVD, the best health outcomes possible. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Rebekah Buckley
NationalCVH@cdc.gov Email:NationalCVH@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 342935 Full Announcement-Full Announcement -> Foa_Content_of_CDC-RFA-DP-23-0004.pdf
Packages
| Agency Contact Information: | Rebekah Buckley NationalCVH@cdc.gov Email: NationalCVH@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.426 | CDC-RFA-DP-23-0004 | The National Cardiovascular Health Program | PKG00280110 | Feb 24, 2023 | Apr 25, 2023 | View |
Package 1
Mandatory forms
342935 SF424_4_0-4.0.pdf
342935 Project_AbstractSummary_2_0-2.0.pdf
342935 SFLLL_2_0-2.0.pdf
342935 SF424A-1.0.pdf
342935 BudgetNarrativeAttachments_1_2-1.2.pdf
342935 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
342935 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
